As NKG2A inhibitory signal is elicited by binding to HLA-I, we analyzed the ability of the different NKp46+CD3− cell populations to lyse HLA-I+ (Caco2) or HLA-I− (HCT15) CRC cell lines. This evidence concerns the gene NCR1 and colorectal carcinoma.